RU2010154081A - Эпитопные пептиды iqgap3 вакцины, содержащие их - Google Patents

Эпитопные пептиды iqgap3 вакцины, содержащие их Download PDF

Info

Publication number
RU2010154081A
RU2010154081A RU2010154081/04A RU2010154081A RU2010154081A RU 2010154081 A RU2010154081 A RU 2010154081A RU 2010154081/04 A RU2010154081/04 A RU 2010154081/04A RU 2010154081 A RU2010154081 A RU 2010154081A RU 2010154081 A RU2010154081 A RU 2010154081A
Authority
RU
Russia
Prior art keywords
amino acid
peptide
seq
acid sequence
group
Prior art date
Application number
RU2010154081/04A
Other languages
English (en)
Russian (ru)
Inventor
Такуя ЦУНОДА (JP)
Такуя Цунода
Рюдзи ОХСАВА (JP)
Рюдзи ОХСАВА
Сатико ЙОСИМУРА (JP)
Сатико Йосимура
Томохиса ВАТАНАБЕ (JP)
Томохиса Ватанабе
Original Assignee
Онкотерапи Сайенс, Инк. (Jp)
Онкотерапи Сайенс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Онкотерапи Сайенс, Инк. (Jp), Онкотерапи Сайенс, Инк. filed Critical Онкотерапи Сайенс, Инк. (Jp)
Publication of RU2010154081A publication Critical patent/RU2010154081A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2010154081/04A 2008-06-11 2009-06-10 Эпитопные пептиды iqgap3 вакцины, содержащие их RU2010154081A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6053808P 2008-06-11 2008-06-11
US61/060,538 2008-06-11

Publications (1)

Publication Number Publication Date
RU2010154081A true RU2010154081A (ru) 2012-07-20

Family

ID=41416549

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010154081/04A RU2010154081A (ru) 2008-06-11 2009-06-10 Эпитопные пептиды iqgap3 вакцины, содержащие их

Country Status (13)

Country Link
US (1) US20110200626A1 (enExample)
EP (1) EP2303909A4 (enExample)
JP (1) JP2011523937A (enExample)
KR (1) KR20110036903A (enExample)
CN (1) CN102119169A (enExample)
AU (1) AU2009258788A1 (enExample)
BR (1) BRPI0915527A2 (enExample)
CA (1) CA2727485A1 (enExample)
IL (1) IL209869A0 (enExample)
MX (1) MX2010013680A (enExample)
RU (1) RU2010154081A (enExample)
TW (1) TW201000115A (enExample)
WO (1) WO2009150835A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI580431B (zh) 2008-08-19 2017-05-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201134480A (en) * 2010-04-08 2011-10-16 Oncotherapy Science Inc CLUAP1 peptides and vaccines including the same
IL292864A (en) 2015-08-28 2022-07-01 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201515321D0 (en) * 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
KR102292655B1 (ko) 2017-04-26 2021-08-23 지브이에스 필트레이션, 인코포레이티드 다중 비드 에어 필터 씰
CN112521455B (zh) * 2020-12-08 2022-09-02 长春理工大学 一种检测膀胱癌抗原蛋白特异性的多肽及其应用
CN118930633A (zh) * 2023-05-12 2024-11-12 中国科学院深圳先进技术研究院 肿瘤相关抗原表位肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP2011885B1 (en) * 2005-02-10 2015-04-22 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
WO2007013665A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
CN101273144B (zh) * 2005-07-27 2011-12-28 肿瘤疗法科学股份有限公司 诊断食道癌的方法

Also Published As

Publication number Publication date
WO2009150835A1 (en) 2009-12-17
EP2303909A1 (en) 2011-04-06
CA2727485A1 (en) 2009-12-17
AU2009258788A1 (en) 2009-12-17
MX2010013680A (es) 2011-02-23
KR20110036903A (ko) 2011-04-12
CN102119169A (zh) 2011-07-06
JP2011523937A (ja) 2011-08-25
IL209869A0 (en) 2011-02-28
TW201000115A (en) 2010-01-01
BRPI0915527A2 (pt) 2016-01-26
US20110200626A1 (en) 2011-08-18
EP2303909A4 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
RU2010154081A (ru) Эпитопные пептиды iqgap3 вакцины, содержащие их
RU2009141595A (ru) Пептиды тем8 и содержащие их вакцины
RU2011110504A (ru) Эпитопные пептиды inhbb и вакцины, содержащие данные пептиды
RU2011138160A (ru) Пептиды foxmi и вакцины, содержащие их
RU2010154101A (ru) Пептиды эпитопов mybl2 и содержащие их вакцины
RU2011101709A (ru) Cdca1 эпитоп-пептиды и содержащие их вакцины
RU2009118432A (ru) Пептидные вакцины против рака с экспрессией полипептидов mphosph1 или depdc1
JP2010523471A5 (enExample)
RU2013112616A (ru) Пептид cdca1 и включающее его фармацевтическое средство
RU2010110545A (ru) Cdh3-пептид и включающее его лекарственное средство
JP2011524737A5 (enExample)
JP2012500001A5 (enExample)
JP2008530975A5 (enExample)
RU2009129531A (ru) Вакцины на основе пептида foxp3
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
RU2011110376A (ru) Эпитопные пептиды hig2 и urlc10 и содержание их вакцины
RU2012136464A (ru) Модифицированные пептиды melk и содержащие их вакцины
RU2014121502A (ru) Пептиды торк и содержащие их вакцины
RU2010126154A (ru) Эпитопные пептиды stat3
JP2011529683A5 (enExample)
RU2013158399A (ru) Пептиды sema5b и содержащие их вакцины
RU2012147590A (ru) Пептиды cdca5 и содержащие их вакцины
RU2015113436A (ru) Пептиды ube2t и содержащие их вакцины
RU2014109137A (ru) Пептиды mphosph1 и вакцины, включающие их
RU2011130796A (ru) Пептиды c1orf59 и содержащие их вакцины

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20130627